The Clinical Effects of Leukocyte-Depleting Filter on Cardiopulmonary Bypass

체외순환 시 백혈구 제거필터 사용의 임상효과

  • 박경택 (인제대학교 의과대학 부산 백병원 흉부외과학 교실) ;
  • 최석철 (인제대학교 의과대학 부산 백병원 흉부외과 체외순환 연구실) ;
  • 최국렬 (인제대학교 데이터정보학과) ;
  • 정석목 (인제대학교 의과대학 부산 백병원 흉부외과 체외순환 연구실) ;
  • 최강주 (인제대학교 의과대학 부산 백병원 흉부외과학 교실)
  • Published : 2001.06.01

Abstract

Background: It has been recognized that systemic inflammatory reaction and oxygen free radical formed by activated leukocyte in the procedure of cardiopulmonary bypass(CPB) frequently produce postoperative cardiac and pulmonary dysfunction. The purpose of this study was to evaluate the efficacy of leukocyte-depleting filters in the cardiopulmonary bypass circuit for patients undergoing open heart surgery(OHS). Material and method: The study involved 15 patients who underwent OHS with a Leukoguard-6 leukocyte filter placed in the arterial limbs of the bypass circuit(filter group, n=15) and 15 patients who did not have the filter(control group, n=15). We analyzed the differences between the groups in intraoperative changes of peripheral blood leukocyte and platelet counts, pre- and postbypass changes of malondialdehyde(MDA), troponin-T(TnT), 5'-nucleotidase(5'-NT) in coronary sinus blood, spontaneous recovery rate of heart beat after CPB, pre-and postoperative cardiac index(Cl) and pulmonary vascular resistance(PVR), and the amounts of postoperative bleeding and sternal wound complication. Result: During CPB, total leukocyte count of the filter group(9,567$\pm$ 842/㎣) was significantly less than that of the control group(13,573+1,167/㎣) (p<0.01), but there was no significant difference in platelet count between the groups. Postoperative levels of MDA(3.78+0.32 $\mu$mol/L vs 5.86+0.65 $\mu$mo1/L, p<0.01), TnT(0.40$\pm$0.04 ng/mL vs 0.59$\pm$0.08 ng/mL, p<0.05) and 5'-NT(3.88$\pm$0.61 U/L vs 5.80$\pm$0.90 U/L, p<0.05) were all significantly lower in the filter group than the control group. Postoperative Cl was higher in the filter group than the control group(3.26$\pm$0.18 L/$m^2$min vs 2.75$\pm$0.17 L/$m^2$/min, p=0.05). PVR of the filter group was lower than that of the control group(65.87$\pm$7.59 dyne/sec/cm$^{5}$ vs 110.80+12.22 dyne/sec/cm$^{5}$ , p<0.01). Spontaneous recovery rate of heart beat in the filter group was higher than that in the control group(12 patients vs 8 patients, p<0.05). Postoperative wound infection occurred in one case in the filter group and 4 case in the control group(p<0.05). Postoperative 24 hour blood loss of the filter group was more than that of the control group (614$\pm$107 mL vs 380+71 mL, p=0.05).

배경: 개심술 시 체외순환회로 및 산화기의 합성표면에 대한 혈액의 접촉은 백혈구를 활성화시켜 전신 염증 반응을 일으키며, 활성화된 백혈구에 의해 생성된 산소유리기는 수술 후 심장 및 폐기능 손상의 주요 원인이 된다. 저자들은 체외순환동안 백혈구 제거필터 사용에 따른 임상효과를 평가하기 위해 본 연구를 실시하였다. 대상 및 방법: 성인 심장질환 환자 30명을 대상으로 백혈구 제거필터를 체외순환 회로에 포함시켜 수술한 필터군(n=15)과 필터를 사용하지 않은 대조군(n=15)으로 분류한 뒤, 테외순환 동안 말초혈액 내 백혈구 및 혈소판 수의 변화, 체외순환 전과 후의 관상정맥동혈액 내 malondialdehyde(MDA), troponin-T(TnT), 5'-nucleotidase(5'-NT의 농도변화, 대동맥 교차차단 해제 후 심박동 자연회복률, 수술 전과 후의 심장지수 및 폐혈관 저항의 변화, 수술 후 출혈량, 혈액제제 사용량과 창상 합병증 발생률 등을 양 군간에 비교하였다. 결과: 체외순환 종료 시 총 백혈구 수는 필터군이 대조군에 비해 유의하게 낮았으나(9,567$\pm$842/㎣ vs 13,573$\pm$1,167/㎣, p<0.01), 혈수판 수는 양 군간에 차이가 없었다(138,133$\pm$10,519/㎣ va 156,733$\pm$10,735/㎣, p=0.22). 수술 직후 관상정맥동 혈액내 MDA(3.78$\pm$0.31$\mu$mo1/L vs 5.86$\pm$0.65$\mu$mo1/L, p<0.01), TnT(0.40$\pm$0.04 ng/mL vs 0.59$\pm$0.08 ng/mL, p<0.05), 그리고 5'-NT(3.88$\pm$0.61 U/L vs 5.08 $\pm$0.90 UL, p<0.05) 등의 활성도는 필터군이 대조군 보다 더 낮았다(p<0.05). 수술후 심장지수는 필터군이 대조군보다 높았고(3.26$\pm$0.18 L/$m^2$/min vs 2.75$\pm$0.17 L/$m^2$/min, p=0.05), 폐혈관 저항은 필터군이 대조군 보다 낮았다(65.87$\pm$7.59 dyne/sec/ $cm^{5}$ vs 110.80$\pm$12.22 dyne/sec/$cm^{5}$ , p.0.01). 수술 후 심박동 자연회복률은 필터군이 대조군 보다 높았고(12명 vs 8명, p<0.05), 수술 후 창상합병증 발생률은 필터군이 대조군보다 낮았다(1명 vs 4명, p<0.05). 수술 후 첫 24시간 출혈량은 필터군이 대조군보다 많았다.(614$\pm$ 107 mL vs 380$\pm$71 mL, p=0.05).

Keywords

References

  1. J Thorac Cardiovasc Surg v.106 Cytokine and complement levels in patients undergoing cardio-pulmonary bypass Steinberg JB;Kapelanski DP;Olson JD (et al)
  2. J Thorac Cardiovasc Surg v.104 Neutrophil activation during cardiopulmonary bypass Finn A;Rebuck N;Moat N
  3. Am J Pathol v.111 Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog Engler RL;Schmid-Schonbein GW;Pavlaei RS
  4. Am J Med Sci v.292 Review;Oxidative injury to the vascular endothelium Warren JS;Ward PA
  5. Annu Rev Pharmacol Toxicol v.26 Leukocytes and ischemia-induced myocardial injury Lucchesi BR;Mullane KM
  6. J Thorac Cardiovasc Surg v.97 Prevention of reperfusion injury in the neonatal heart with leukocyte-depleted blood Breda MA;Drinkwater DC;Laks H (et al)
  7. J Thorac Cardiovasc Surg v.99 Leukocyte depletion ameliorates free radical-mediated lung injury after cardiopulmonary bypass Bando K;Pillai R;Cameron DE (et al)
  8. J Thorac Cardiovasc Surg v.106 Temporary leukocyte depletion reduces ventricular dysfunction during prolonged postischemic reperfusion Wilson IC;Gardner TJ;Dinatale JM (et al)
  9. J Thorac Cardiovasc Surg v.112 Leukocyte depletion results in improved lung function and reduced inflammatory response after cardiac surgery Gu YJ;de Vries AJ;Boonstra PW;van Oeveren W
  10. Am J Physiol v.256 Influence of neutrophil depletion on myocardial function and flow after reversible ischemia O'neil PG;Charlat ML;Michael LH;Roberts R;Bolli R
  11. J Thorac Cardiovasc Surg v.109 The influence of leukocyte filtration during cardiopulmonary bypass on postperative lung function Mihaljevic T;Tonz M;von Segesser LK (et al)
  12. Perfusion v.13 Leucocyte filtration during cardiopulmonary bypass hardly changed leukocyte counts and did not influence myeloperoxidase, complement, cytokines or platelets Baksaas ST;Videm V;Mollnes TE (et al0
  13. Perfusion v.14 Leucocyte-depleted cardioplegia does not reduce reperfusion injury hypothermic coronary artery bypass surgery Browning PG;Pullan M;Jackson M;Rashid A
  14. Am J Pathol v.107 Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflam-matory reactions Fantone JC;Ward PA
  15. Blood v.65 Leukocyte-endothelial interations Harlan J
  16. Circ Res v.53 Hydrogen peroxide and hydroxyl radical mediation of activated leukocyte depression of cardiac sarcoplasmic reticulum;participation of the cyclo-cxygenase pathway Rowe G;Manson N;Caplan M;Hess M
  17. J Thorac Cardiovasc Surg v.91 Increased production of peroxidation products associated with cardiac operation;evidence for free radical generation Rouston D;Fleming JS;Desai JB;Westaby S;Tayer KM
  18. Ann Thorac Surg v.62 Lung preservation;the importance of endothelial and alveolar type II cell integrity Novick RJ;Gehman KE;Ali IS;Lee J
  19. Circulation v.93 Leukocyte depletion attenuates reperfusion injury in patients with left ventricular hypertrophy Sawa Y;Taniguchi K (et al)
  20. Surg Forum v.40 Neonatal functional tolerance to ischemia-reperfusion may be induced in adult myocardium by 5'-nucleotidase Grosso MA;Banergee A;Brown JM (et al)
  21. J Thorac Cardiovasc Surg v.103 Enhanced myocardial protection during global ischemia with 5'-nucleotidase inhibitors Bolling SF;Olszanski DA;Bove EL;Childs KF
  22. Ann Thorac Surg v.67 Reduced neutrophil infiltration protects against lung reperfusion injury after transplatation Ross SD;Tribble CG;Gaughen JR
  23. J. Thorac Cardiovasc Surg v.113 Prevention of the hypoxic reoxygenation injury with the use of leukocyte-depleting filter Bolling KS;Halldosson A;Allen BS (et al)
  24. Ann Thorac Surg Lukocyte depletionresults in excellent heart-lung function after 12 hours of storage Pillai R;Bando K;Schueler S (et al)
  25. J Thorac Cardiovasc Surg v.108 Evaluation of leukocyte-deplated terminal blood cardioplegic solution in patients undergoing elective and emergency coronary artery bypass grafting Sawa Y;Matsuda H;Shimazaki Y (et al)
  26. Ann Thorac Surg v.67 Leukocyte depletion during cardiac operation;A new approach through the venous bypass circuit Gu YJ;de Vries AJ;Vos P;Boonstra PW;van Oeveren W.
  27. Ann Thorac Surg v.65 Effects of depletion of leukcytes and platelets on cardiac dysfunction after cardiopulmonary bypass Chiba Y;Morioka K;Muraoka R (et al)
  28. Perfusion v.8 Clinical evaluation of the LeukoGuard(LG-6) arterial line filter for routine open-heart surgery Palanzo DA;Manley NJ;Montesano RM;Yeisley GL;Gordon D
  29. J Thrac Cardiovasc Surg v.111 Leukocyte and platelet depletion with a blood cell separator;effects on lung injury after cardiac surgery with cardiopulmonary bypass Morika K;Muraoka R;Chiba Y (et al)
  30. J Thorac Cardiovasc Surg v.84 Release of lysosomal hydrolases during extracoreal circulation Addonizio VP Jr;Chang LK;Strauss JR III (et al)
  31. Blood v.56 Mechanism of abnormal bleeding in patients undergoing cardio-pulmonary bypass;acquired transient platelet dysfunction associated with selective granule release Harker LA;Malpass TW;Branson HE (et al)
  32. Blood Rev v.6 Platelet-neutrophil interactions;their signi-ficance Faint RW
  33. Cell v.59 PADGEM protein-a receptor that mediates the interaction of activated platelets with neutrophis and moncytes Larsen E;Celi A;Gilbert GE (et al)
  34. J Thorac Cardiovasc Surg v.84 Platelet deposition after surgically induced myocardial ischemia;an etiologic factor for reperfusion injury Feinberg H;Rosenbaum DS;Levitsky S (et al)
  35. J Appl Physiol v.50 Platelet sequesration in lung with hemorrhagic shock and reinfusion in dogs Martin BA;Dahlby R;Nicholls I;Hogg TC